QMA State Test 2026 – 450+ Exam Questions & Verified Answers – Pharmacology, Controlled Substances & Resident Care

This document contains 450+ comprehensive QMA State Test exam questions and verified answers for the 2026 certification cycle. It provides extensive coverage of medication administration principles, pharmacology classifications, controlled substance regulations, cardiovascular and respiratory medications, endocrine disorders, infection control, emergency response procedures, ostomy care, and long-term care nursing responsibilities. The structured question-and-answer format reinforces exam readiness and clinical application for medication aides in state-regulated settings. The material begins with foundational cardiovascular and ophthalmic concepts (arteries carrying blood away from the heart, myocardial ischemia causes, glaucoma definition and treatment with miotics and beta blockers, cataract causes and management) as seen in the early pages of the document. It progresses into detailed pharmacology review including diuretics (Lasix, Aldactone, Bumex), anti-ulcer agents (Pepcid, Protonix, Prilosec), NSAIDs, corticosteroids, analgesics (morphine, tramadol, hydromorphone), laxatives (bulk-forming, stool softeners, stimulant, saline), cardiotonics (digoxin), antihypertensives (ACE inhibitors, beta blockers, calcium channel blockers), vasodilators (nitroglycerin), and anticoagulants (Heparin, Warfarin). Respiratory medications are thoroughly reviewed, including bronchodilators (albuterol, ipratropium), antihistamines, antitussives, expectorants, decongestants, and oxygen therapy considerations. The guide clearly outlines oxygen saturation norms (97–99%), signs of respiratory distress, and the drying effect of oxygen on mucous membranes. Endocrine coverage includes diabetes pathophysiology, oral hypoglycemics, insulin interactions, early and late signs of hypoglycemia and hyperglycemia, diabetic foot care, sick-day management, and thyroid hormone replacement (levothyroxine). Neurological and psychiatric medications are also extensively addressed, including anticonvulsants (Depakote, Tegretol, Lamictal), Parkinson’s medications (Sinemet), antidepressants (tricyclics and MAOIs), bipolar medications (lithium, Depakote), anxiolytics (Ativan, Xanax, Buspar), and antipsychotics (Risperdal, Seroquel, Haldol). Adverse effects such as tardive dyskinesia, hypertensive crisis risk with MAOIs, lithium toxicity, and sedation are clearly explained. Legal and regulatory content is strongly emphasized, including the Six Rights of Medication Administration, controlled substance scheduling (Schedules I–V with examples), narcotic count procedures (count when keys exchange hands), PRN authorization requirements, documentation standards, objective vs. subjective observations, medication error reporting, and QMA scope of practice limitations. Infection control principles (airborne, droplet, contact precautions), seizure management, fire safety (RACE and PASS), positioning guidelines (Sims, Fowler’s, lateral), and ostomy care are also comprehensively covered. This resource is ideal for: QMA State certification candidates CNA to QMA bridge students Long-term care medication aides Skilled nursing facility staff Nursing assistant students preparing for medication credentialing State medication aide competency exam candidates It is relevant for preparation programs such as: Qualified Medication Aide State Exam Preparation Long-Term Care Medication Administration Certification CNA to QMA Transition Programs Pharmacology for Medication Aides State Medication Aide Competency Review Keywords: QMA State Test 2026, Qualified Medication Aide Exam Questions, Six Rights of Medication Administration, Controlled Substances Schedule II III IV V, Digoxin Nursing Considerations, ACE Inhibitors and Beta Blockers, Bronchodilators and Antihistamines, Oral Hypoglycemics Diabetes Care, Hypoglycemia Early and Late Symptoms, Oxygen Saturation Normal Range, Anticoagulant Monitoring Warfarin Heparin, Lithium Toxicity Signs, Anticonvulsant Nursing Considerations, Infection Control Precautions, PRN Medication Authorization